The short answer
Scans, biopsies and blood tests measure different things, so they can appear to disagree. Tissue from a biopsy is usually the deciding evidence, and a tumor board weighs the whole picture.
Each test answers a different question. Imaging shows shape and size, biopsy shows what the cells actually are, and blood tests measure substances that can rise for many reasons.
Tissue is usually decisive. Imaging can suggest cancer, but a diagnosis is generally confirmed by a pathologist looking at cells.
Tumor markers alone cannot diagnose cancer. Noncancerous conditions raise them, some people with cancer have normal levels, and some healthy people have raised levels.
A negative biopsy from an area that looks suspicious on imaging may mean the needle missed the target rather than that there is no cancer.
Choose how you want to understand this
The full explanation.
Three Tests, Three Different Questions
Your scan, your biopsy and your bloods can appear to say different things. It can feel as though the system has lost track of your case. Usually the tests have not contradicted each other at all. They were never answering the same question.
- Imaging answers what shape is there and how big is it? It sees density, structure and metabolic activity. It does not see identity.
- Biopsy answers what are these cells? It looks directly at tissue. It is the only test that can name a cancer with confidence.
- Blood tests answer how much of a particular substance is circulating? That substance may come from cancer, or from something else entirely.
Asking three tools with three different jobs to agree exactly is asking more of them than they were built to give.
Why Each One Can Mislead
Imaging cannot tell cancer apart from inflammation, infection, scar or benign growth with certainty. Enlarged lymph nodes are often just reacting to something. PET highlights metabolic activity, and infection and healing tissue produce that too. Very small deposits are invisible altogether.
Biopsy is limited by where the needle went. A core taken a few millimetres from the abnormal area returns normal tissue. That result is a true description of what was sampled. It is also false reassurance about the lesion. Interpretation involves judgement as well, and some distinctions are genuinely difficult even for experienced pathologists.
Blood tests are the least specific. As NCI explains, noncancerous conditions can raise tumor marker levels. Not everyone with a given cancer has a raised marker. And marker measurements are usually combined with biopsy and imaging rather than used alone. A single abnormal value is a prompt to look further, not a diagnosis.
Why the Biopsy Usually Wins
Tissue carries the most information. A pathologist can see how the cells are arranged. They can run immunohistochemical stains, which show which proteins a cell is making and so point to the tissue it came from. They can also run molecular testing, which shows which treatments will work. Imaging and blood tests can suggest. Tissue identifies.
But this only holds when the biopsy actually sampled the lesion in question. That is why a negative biopsy from a lesion that looks convincingly malignant on imaging is treated as an unresolved question, not an all-clear. Radiologists and pathologists specifically review such cases together. A repeat biopsy, a larger sample, or surgical removal is often recommended.
How a Tumor Board Resolves It
Most cancer centers run multidisciplinary tumor boards. These are scheduled meetings where a radiologist, a pathologist, a surgeon, a medical oncologist, a radiation oncologist and often nursing and palliative care colleagues review a case together.
In a case where results disagree, the discussion typically works through:
- Does the tissue match the picture? The pathologist and radiologist compare what was sampled with where the abnormality actually sits.
- Was the sample adequate? A small or crushed sample may not support a firm conclusion.
- Does the biology make sense? A diagnosis that does not fit the pattern of spread, or the course so far, prompts a re-look.
- What single test would resolve this? Often a repeat biopsy, a different imaging method, a second pathology opinion, or simply repeating the scan after a set interval.
Second-opinion pathology review is a routine part of this at many centers. It sometimes changes a diagnosis or a subtype. Requesting it is not an accusation.
Time Is Sometimes the Test
When no result is urgent and the tests conflict, repeating a scan after an interval can tell you more than adding another test now. Something that grows behaves differently from something that does not, and stability over months is itself evidence. If your team suggests waiting, it is fair to ask what they expect to see and what would change the plan.
What You Can Do
Ask which result they are weighting most heavily, and why. Ask whether your case has gone to a tumor board and what was concluded. Ask whether a repeat biopsy or a second pathology read would change anything. Keep copies of your reports so you can see the sequence yourself.
Living inside an unresolved result is genuinely hard. Name what is still unknown, and what would settle it. That usually makes the wait more bearable than trying to force a conclusion the evidence does not yet support.
Sources
Words to know
Tap any term to see what it means.
Common questions
My scan says something suspicious but my biopsy was negative. Which do I believe?
Neither on its own. This combination is described as discordant, and it is taken seriously rather than dismissed. The usual interpretation is that the needle may not have hit the abnormality, which is why radiologists and pathologists review such cases together and often recommend repeating the biopsy, sampling a different part of the lesion, or removing it surgically. A negative biopsy is only as reliable as the accuracy of the sampling.
My tumor marker went up but my scans are stable. Should I be worried?
A single rise is generally not acted on. Markers fluctuate, and noncancerous conditions can raise them. As NCI notes, marker results are usually combined with other tests rather than used alone. Most teams will repeat the test after an interval and look at the trend. A steady climb across several measurements carries more weight than one abnormal value.
What is a tumor board and can I ask for one?
It is a scheduled meeting where specialists from different disciplines review a case together: radiology, pathology, surgery, medical oncology, radiation oncology and often nursing and palliative care. Many cancer centers review every new case routinely. You can ask whether yours has been discussed and what the meeting concluded.
Why would two pathologists read the same slide differently?
Pathology involves expert interpretation, not just measurement, and certain distinctions are genuinely difficult — rare tumor types, lymphoma subtyping, borderline grading, and telling reactive changes from cancer. Second-opinion review at a specialist center sometimes changes a diagnosis or a subtype, which is why it is routine practice at many cancer centers rather than a sign of doubt about anyone's competence.
Is it reasonable to ask for more time before deciding?
Often yes, and sometimes waiting is the plan. When results conflict and none of them is urgent, repeating a scan after a defined interval can resolve the question better than another test now, because change over time is itself evidence. Ask your team directly whether a short delay carries any risk in your situation.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-07-30 what this meansLast updated: 2026-08-10Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share